Scholarlink

Purpose <p>Up-to-date national data on minimally invasive cardiac surgery (MICS) are essential for quality control but remain limited. This report summarizes 2022 outcomes of right- or left-minithoracotomy, thoracoscopic/port-assisted, and robotic-assisted MICS in Japan, based on the Japan Cardiovascular Surgery Database (JCVSD).</p> Methods <p>Data were collected from patients undergoing mitral valve repair/replacement (MV repair, <i>n</i> = 2525; MVR, <i>n</i> = 279), aortic valve replacement (AVR, <i>n</i> = 1114), coronary artery bypass grafting (CABG, <i>n</i> = 450), atrial septal defect closure (ASD, <i>n</i> = 212), and cardiac tumor resection (<i>n</i> = 113) using MICS approaches. Perioperative data included 30-day and in-hospital mortality, conversion rates, and major morbidities.</p> Results <p>For MV repair, the 30-day and in-hospital mortality rates were 0.3% and 0.2% in isolated cases (<i>n</i> = 1461) and 0.4% and 0.6% overall, respectively. Mortality rates for MVR were 2.5% and 4.2% in isolated cases (<i>n</i> = 120) and 2.9% and 4.3% overall, respectively. Mortality rates for AVR were 0.6% and 1.0% in isolated cases (<i>n</i> = 981) and 0.9% and 1.3% overall, respectively. Mortality rates for CABG were 1.6% and 1.8%, respectively. Mortality rates were 0% for both ASD closure and tumor resection. Across the groups, conversion to full sternotomy ranged from 0% to 1.8%.</p> Conclusion <p>The 2022 nationwide MICS data demonstrate consistently low mortality and morbidity across all procedure types. As MICS adoption grows, these updated JCVSD findings will serve as vital benchmarks for ongoing quality improvement in Japan.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Minimally invasive cardiac surgeries in 2022: annual report by Japanese Society of Minimally Invasive Cardiac Surgery

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月19日

查看全文
  • Tomoki Shimokawa,
  • Hiraku Kumamaru,
  • Noboru Motomura,
  • Hiroyuki Nishi,
  • Hiroyuki Nakajima,
  • Hiroyuki Kamiya,
  • Kazuma Okamoto,
  • Soh Hosoba,
  • Yoshikatsu Saiki,
  • Takashi Miura,
  • Minoru Tabata,
  • Akira Shiose,
  • Taichi Sakaguchi

摘要

Purpose

Up-to-date national data on minimally invasive cardiac surgery (MICS) are essential for quality control but remain limited. This report summarizes 2022 outcomes of right- or left-minithoracotomy, thoracoscopic/port-assisted, and robotic-assisted MICS in Japan, based on the Japan Cardiovascular Surgery Database (JCVSD).

Methods

Data were collected from patients undergoing mitral valve repair/replacement (MV repair, n = 2525; MVR, n = 279), aortic valve replacement (AVR, n = 1114), coronary artery bypass grafting (CABG, n = 450), atrial septal defect closure (ASD, n = 212), and cardiac tumor resection (n = 113) using MICS approaches. Perioperative data included 30-day and in-hospital mortality, conversion rates, and major morbidities.

Results

For MV repair, the 30-day and in-hospital mortality rates were 0.3% and 0.2% in isolated cases (n = 1461) and 0.4% and 0.6% overall, respectively. Mortality rates for MVR were 2.5% and 4.2% in isolated cases (n = 120) and 2.9% and 4.3% overall, respectively. Mortality rates for AVR were 0.6% and 1.0% in isolated cases (n = 981) and 0.9% and 1.3% overall, respectively. Mortality rates for CABG were 1.6% and 1.8%, respectively. Mortality rates were 0% for both ASD closure and tumor resection. Across the groups, conversion to full sternotomy ranged from 0% to 1.8%.

Conclusion

The 2022 nationwide MICS data demonstrate consistently low mortality and morbidity across all procedure types. As MICS adoption grows, these updated JCVSD findings will serve as vital benchmarks for ongoing quality improvement in Japan.